Lung Cancer Dispatch
Follow
Find tag "chemoprevention"
3.9K views | +0 today
Lung Cancer Dispatch
News for Patients and Physicians
Curated by Cancer Commons
Your new post is loading...
Your new post is loading...
Suggested by Cancer Commons
Scoop.it!

Selenium Does Not Prevent Lung Cancer Recurrence

Selenium has been suggested to have preventative effects against lung cancer. In a recent clinical trial, patients with stage I non-small cell lung cancer (NSCLC) that had been completely surgically removed were given either selenium supplements or a placebo for 2 years after surgery. Interim results showed that patients receiving selenium were no less likely to have their lung cancer return than those given a placebo. Because there were hints that selenium-treated patients may be indeed more likely to develop new tumors, the study was halted. Final analyses show no harm from taking selenium, but no protection against lung cancer either.

Cancer Commons's insight:

Journal of Clinical Oncology | Sep 3, 2013

more...
No comment yet.
Suggested by Cancer Commons
Scoop.it!

Two New Books Offer History and Criticism of Cancer Research

Two New Books Offer History and Criticism of Cancer Research | Lung Cancer Dispatch | Scoop.it

Despite billions of dollars invested in cancer research and high-profile anti-cancer government initiatives, millions of people continue to die of cancer every year. In his forthcoming book The Truth in Small Doses, Clifton Leaf blames the cancer research field for being too risk-averse and unreceptive to new ideas. He calls on researchers to explore fundamentally novel approaches, including chemoprevention, i.e., treatments aimed at preventing cancer before it develops in the first place. On the other hand, the cautious research practices decried by Leaf minimize the risk of patients being harmed by unproven, hastily adopted methods. Cautionary examples of such incidents are included in Siddhartha Mukherjee’s The Emperor of All Maladies, a history of cancer and its treatment.

Cancer Commons's insight:

New Yorker | Jul 1, 2013

more...
No comment yet.
Suggested by Cancer Commons
Scoop.it!

Daily Aspirin Linked to Smaller Tumors in Lung and Colon Cancer

A retrospective analysis of data from thousands of cancer patients showed that lung and colon cancer patients who had been taking daily low-dose aspirin before diagnosis had smaller tumors. Their cancer was also 20% to 40% less likely to have spread to other parts of the body. It is still unclear whether aspirin indeed caused the less severe diagnoses or whether separate, independent factors make people both more likely to take daily aspirin and to have less advanced lung or colon cancers. Future studies may address this question. No association between daily aspirin and cancer severity was found in prostate or breast cancer.

Cancer Commons's insight:

Reuters | Aug 16, 2013

more...
Cancer Commons's curator insight, August 23, 2013 1:14 PM

Reuters | Aug 16, 2013